ARGS - Argos Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPS-11.6-4.2N/AN/A
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate50k50k200k500k
Low Estimate50k50k200k500k
High Estimate50k50k200k500k
Year Ago Sales105k70k1.9M200k
Sales Growth (year/est)-52.40%-28.60%-89.50%150.00%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.-7-5.2-4-1.4
EPS Actual-11.6-4.2-2-0.93
Difference-4.6120.47
Surprise %-65.70%19.20%50.00%33.60%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate0000
7 Days Ago-1.8-1.8-7-0.21
30 Days Ago-1.8-1.8-7-0.21
60 Days Ago-1.8-1.8-7-0.21
90 Days Ago-1.8-1.8-7-0.21
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesARGSIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.42
Next Qtr.N/AN/AN/A0.45
Current YearN/AN/AN/A0.21
Next YearN/AN/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A